Aliskiren, the first in a new class of direct renin inhibitors for hypertension: present and future perspectives
Author:
Affiliation:
1. Seoul National University College of Medicine, Department of Internal Medicine, 28 Yongon-dong, Jongno-gu, Seoul, 110-744, Korea ; ;
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1517/14656566.8.16.2839
Reference36 articles.
1. Structure-based design of aliskiren, a novel orally effective renin inhibitor
2. Global burden of hypertension: analysis of worldwide data
3. WHO: World health report 2002; reducing risk, promoting healthy life. (Eds), World Health Organization, Geneva, Switzerland (2002).
4. Pathways for Angiotensin II Generation in Intact Human Tissue
5. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enantioselective Synthesis of α-Chiral Amides by Catalytic Hydrogenation with Iridium N,P-Complexes;Synlett;2022-12-22
2. Molormer: a lightweight self-attention-based method focused on spatial structure of molecular graph for drug–drug interactions prediction;Briefings in Bioinformatics;2022-07-19
3. Pharmacogenomics Informs Cardiovascular Pharmacotherapy;Methods in Molecular Biology;2022
4. Aliskiren, the first direct renin inhibitor: assessing a role in pediatric hypertension and kidney diseases;Pediatric Nephrology;2013-12-14
5. Reducing Cardiovascular Events and End-Organ Damage in Patients with Hypertension: New Considerations;Postgraduate Medicine;2011-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3